Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

Gene expression of Aspergillus flavus strains on a cheese model system to control aflatoxin production.

Casquete R, Benito MJ, Aranda E, Martín A, Ruiz-Moyano S, de Guía Córdoba M.

J Dairy Sci. 2019 Jul 10. pii: S0022-0302(19)30604-6. doi: 10.3168/jds.2019-16722. [Epub ahead of print]

PMID:
31301828
2.

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples.

Vivancos A, Aranda E, Benavides M, Élez E, Gómez-España MA, Toledano M, Alvarez M, Parrado MRC, García-Barberán V, Diaz-Rubio E.

Sci Rep. 2019 Jun 20;9(1):8976. doi: 10.1038/s41598-019-45616-y.

3.

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Carrato A, Benavides M, Massutí B, Ferreiro-Monteagudo R, García Alfonso P, Falcó E, Reboredo M, Cano T, Gallego J, Viéitez JM, Layos L, Salud A, Polo E, Dotor E, Durán-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E, Aranda E.

BMC Cancer. 2019 Jun 3;19(1):533. doi: 10.1186/s12885-019-5753-7.

4.

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Borrero-Palacios A, Cebrián A, Gómez Del Pulgar MT, García-Carbonero R, Garcia-Alfonso P, Aranda E, Elez E, López-López R, Cervantes A, Valladares M, Nadal C, Viéitez JM, Guillén-Ponce C, Rodríguez J, Hernández I, García JL, Vega-Bravo R, Puime-Otin A, Martínez-Useros J, Del Puerto-Nevado L, Rincón R, Rodríguez-Remírez M, Rojo F, García-Foncillas J.

Sci Rep. 2019 May 17;9(1):7706. doi: 10.1038/s41598-019-43809-z.

5.

Effect of Composting Under Semipermeable Film on the Sewage Sludge Virome.

Robledo-Mahón T, Silva-Castro GA, Kuhar U, Jamnikar-Ciglenečki U, Barlič-Maganja D, Aranda E, Calvo C.

Microb Ecol. 2019 Apr 29. doi: 10.1007/s00248-019-01365-z. [Epub ahead of print]

PMID:
31037376
6.

Impact of an Andean breakfast on biochemistry and immunochemistry laboratory tests: an evaluation on behalf COLABIOCLI WG-PRE-LATAM.

Bajaña W, Aranda E, Arredondo ME, Brennan-Bourdon LM, Campelo MD, Espinoza E, Flores S, Ochoa P, Vega V, Varela B, Lima-Oliveira G.

Biochem Med (Zagreb). 2019 Jun 15;29(2):020702. doi: 10.11613/BM.2019.020702. Epub 2019 Apr 15.

7.

Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response.

PeÑarando J, Aranda E, RodrÍguez-Ariza A.

Transl Res. 2019 Aug;210:99-108. doi: 10.1016/j.trsl.2019.03.003. Epub 2019 Mar 15. Review.

PMID:
30953610
8.

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Santos C, Azuara D, Viéitez JM, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Aranda E, Salazar R.

Ann Oncol. 2019 May 1;30(5):796-803. doi: 10.1093/annonc/mdz082.

PMID:
30840064
9.

Genome and secretome of Chondrostereum purpureum correspond to saprotrophic and phytopathogenic life styles.

Reina R, Kellner H, Hess J, Jehmlich N, García-Romera I, Aranda E, Hofrichter M, Liers C.

PLoS One. 2019 Mar 1;14(3):e0212769. doi: 10.1371/journal.pone.0212769. eCollection 2019.

10.

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Borrero-Palacios A, Cebrián A, Gómez Del Pulgar MT, García-Carbonero R, Garcia-Alfonso P, Aranda E, Elez E, López-López R, Cervantes A, Valladares M, Nadal C, Viéitez JM, Guillén-Ponce C, Rodríguez J, Hernández I, García JL, Vega-Bravo R, Puime-Otin A, Martínez-Useros J, Del Puerto-Nevado L, Rincón R, Rodríguez-Remírez M, Rojo F, García-Foncillas J.

Sci Rep. 2019 Feb 22;9(1):2589. doi: 10.1038/s41598-019-39291-2. Erratum in: Sci Rep. 2019 May 17;9(1):7706.

11.

First demonstration that ascomycetous halophilic fungi (Aspergillus sydowii and Aspergillus destruens) are useful in xenobiotic mycoremediation under high salinity conditions.

González-Abradelo D, Pérez-Llano Y, Peidro-Guzmán H, Sánchez-Carbente MDR, Folch-Mallol JL, Aranda E, Vaidyanathan VK, Cabana H, Gunde-Cimerman N, Batista-García RA.

Bioresour Technol. 2019 May;279:287-296. doi: 10.1016/j.biortech.2019.02.002. Epub 2019 Feb 2.

PMID:
30738355
12.

Evaluation of diclofenac biodegradation by the ascomycete fungus Penicillium oxalicum at flask and bench bioreactor scales.

Olicón-Hernández DR, Camacho-Morales RL, Pozo C, González-López J, Aranda E.

Sci Total Environ. 2019 Apr 20;662:607-614. doi: 10.1016/j.scitotenv.2019.01.248. Epub 2019 Jan 22.

PMID:
30699381
13.

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.

Vidal J, Bellosillo B, Santos Vivas C, García-Alfonso P, Carrato A, Cano MT, García-Carbonero R, Élez E, Losa F, Massutí B, Valladares-Ayerbes M, Viéitez JM, Manzano JL, Azuara D, Gallego J, Pairet S, Capellá G, Salazar R, Tabernero J, Aranda E, Montagut C.

Ann Oncol. 2019 Mar 1;30(3):439-446. doi: 10.1093/annonc/mdz005.

PMID:
30689692
14.

New Insights of Ustilago maydis as Yeast Model for Genetic and Biotechnological Research: A Review.

Olicón-Hernández DR, Araiza-Villanueva MG, Pardo JP, Aranda E, Guerra-Sánchez G.

Curr Microbiol. 2019 Aug;76(8):917-926. doi: 10.1007/s00284-019-01629-4. Epub 2019 Jan 28. Review.

PMID:
30689003
15.

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.

García-Foncillas J, Tabernero J, Élez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, López R, Muinelo-Romay L, Montagut C, Antón A, López G, Díaz-Rubio E, Rojo F, Vivancos A.

Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

16.

Exploring the response of Marchantia polymorpha: Growth, morphology and chlorophyll content in the presence of anthracene.

Spinedi N, Rojas N, Storb R, Cabrera J, Aranda E, Salierno M, Svriz M, Scervino JM.

Plant Physiol Biochem. 2019 Feb;135:570-574. doi: 10.1016/j.plaphy.2018.11.001. Epub 2018 Nov 3.

PMID:
30429053
17.
18.

Spontaneous Hyperventilation in Severe Traumatic Brain Injury: Incidence and Association with Poor Neurological Outcome.

Esnault P, Roubin J, Cardinale M, D'Aranda E, Montcriol A, Cungi PJ, Goutorbe P, Joubert C, Dagain A, Meaudre E.

Neurocrit Care. 2019 Apr;30(2):405-413. doi: 10.1007/s12028-018-0639-0.

PMID:
30386962
19.

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.

Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Díaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL.

Eur J Cancer. 2018 Nov;103:205-213. doi: 10.1016/j.ejca.2018.08.020. Epub 2018 Sep 27.

PMID:
30268921
20.

Purification and characterization of a fungal laccase from the ascomycete Thielavia sp. and its role in the decolorization of a recalcitrant dye.

Mtibaà R, Barriuso J, de Eugenio L, Aranda E, Belbahri L, Nasri M, Martínez MJ, Mechichi T.

Int J Biol Macromol. 2018 Dec;120(Pt B):1744-1751. doi: 10.1016/j.ijbiomac.2018.09.175. Epub 2018 Sep 27.

PMID:
30268749
21.

Validation of a monitoring matrix for patients with brain injuries.

Cardinale M, Esnault P, d'Aranda E, Meaudre E, Lacroix G.

Injury. 2019 Jan;50(1):79-81. doi: 10.1016/j.injury.2018.09.016. Epub 2018 Sep 9.

PMID:
30224177
22.

Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.

Huaman MA, Henson D, Rondan PL, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Ticona C, Abarca S, Heredia P, Aguirre A, Sterling TR, Garvy BA, Fichtenbaum CJ.

PLoS One. 2018 Sep 13;13(9):e0202191. doi: 10.1371/journal.pone.0202191. eCollection 2018.

23.

Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).

García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

Oncologist. 2018 Nov;23(11):1271-e128. doi: 10.1634/theoncologist.2018-0316. Epub 2018 Aug 17.

24.

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024. Epub 2018 Jul 24.

PMID:
30054049
25.

Schizophyllum commune: An unexploited source for lignocellulose degrading enzymes.

Tovar-Herrera OE, Martha-Paz AM, Pérez-LLano Y, Aranda E, Tacoronte-Morales JE, Pedroso-Cabrera MT, Arévalo-Niño K, Folch-Mallol JL, Batista-García RA.

Microbiologyopen. 2018 Jun;7(3):e00637. doi: 10.1002/mbo3.637. Epub 2018 May 21. Review.

26.

Anthracene drives sub-cellular proteome-wide alterations in the degradative system of Penicillium oxalicum.

Lucero Camacho-Morales R, García-Fontana C, Fernández-Irigoyen J, Santamaría E, González-López J, Manzanera M, Aranda E.

Ecotoxicol Environ Saf. 2018 Sep 15;159:127-135. doi: 10.1016/j.ecoenv.2018.04.051. Epub 2018 May 4.

PMID:
29734068
27.

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.

Irigoyen A, Jimenez-Luna C, Benavides M, Caba O, Gallego J, Ortuño FM, Guillen-Ponce C, Rojas I, Aranda E, Torres C, Prados J.

PLoS One. 2018 Apr 4;13(4):e0194844. doi: 10.1371/journal.pone.0194844. eCollection 2018.

28.

Effect of semi-permeable cover system on the bacterial diversity during sewage sludge composting.

Robledo-Mahón T, Aranda E, Pesciaroli C, Rodríguez-Calvo A, Silva-Castro GA, González-López J, Calvo C.

J Environ Manage. 2018 Jun 1;215:57-67. doi: 10.1016/j.jenvman.2018.03.041. Epub 2018 Mar 20.

PMID:
29558651
29.

A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer.

Grávalos C, Carrato A, Tobeña M, Rodriguez-Garrote M, Soler G, Vieitez JM, Robles L, Valladares-Ayerbes M, Polo E, Limón ML, Safont MJ, Martínez de Castro E, García-Alfonso P, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

Clin Colorectal Cancer. 2018 Jun;17(2):e323-e329. doi: 10.1016/j.clcc.2018.02.004. Epub 2018 Feb 17.

PMID:
29551560
30.

Degradation of bisphenol A and acute toxicity reduction by different thermo-tolerant ascomycete strains isolated from arid soils.

Mtibaà R, Olicón-Hernández DR, Pozo C, Nasri M, Mechichi T, González J, Aranda E.

Ecotoxicol Environ Saf. 2018 Jul 30;156:87-96. doi: 10.1016/j.ecoenv.2018.02.077. Epub 2018 Mar 13.

31.

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.

Arjona-Sánchez A, Barrios P, Boldo-Roda E, Camps B, Carrasco-Campos J, Concepción Martín V, García-Fadrique A, Gutiérrez-Calvo A, Morales R, Ortega-Pérez G, Pérez-Viejo E, Prada-Villaverde A, Torres-Melero J, Vicente E, Villarejo-Campos P, Sánchez-Hidalgo JM, Casado-Adam A, García-Martin R, Medina M, Caro T, Villar C, Aranda E, Cano-Osuna MT, Díaz-López C, Torres-Tordera E, Briceño-Delgado FJ, Rufián-Peña S.

BMC Cancer. 2018 Feb 13;18(1):183. doi: 10.1186/s12885-018-4096-0.

32.

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.

van Rooijen KL, Shi Q, Goey KKH, Meyers J, Heinemann V, Diaz-Rubio E, Aranda E, Falcone A, Green E, de Gramont A, Sargent DJ, Punt CJA, Koopman M.

Eur J Cancer. 2018 Mar;91:99-106. doi: 10.1016/j.ejca.2017.12.014. Epub 2018 Jan 30.

PMID:
29353165
33.

A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer.

Peñarando J, López-Sánchez LM, Mena R, Guil-Luna S, Conde F, Hernández V, Toledano M, Gudiño V, Raponi M, Billard C, Villar C, Díaz C, Gómez-Barbadillo J, De la Haba-Rodríguez J, Myant K, Aranda E, Rodríguez-Ariza A.

BMC Biol. 2018 Jan 10;16(1):3. doi: 10.1186/s12915-017-0472-5.

34.

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.

Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Falcone A, Porschen R, Fuchs C, Diaz-Rubio E, Aranda E, Bokemeyer C, Souglakos I, Kabbinavar FF, Chibaudel B, Meyers JP, Sargent DJ, de Gramont A, Zalcberg JR; Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD).

J Natl Cancer Inst. 2018 Jun 1;110(6):638-648. doi: 10.1093/jnci/djx253.

35.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):79. doi: 10.1007/s11523-017-0544-z.

PMID:
29243205
36.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Abad A, Martínez-Balibrea E, Viéitez JM, Alonso-Orduña V, García Alfonso P, Manzano JL, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E.

Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.

PMID:
29145602
37.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z. Erratum in: Target Oncol. 2017 Dec 14;:.

PMID:
29128908
38.

The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.

Huaman MA, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Rondan PL, Henson D, Ticona C, Sterling TR, Fichtenbaum CJ, Garvy BA.

Clin Infect Dis. 2018 Mar 5;66(6):886-892. doi: 10.1093/cid/cix910.

39.

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients.

Negrouk A, Lacombe D, Cardoso F, Morin F, Carrasco E, Maurel J, Maibach R, Aranda E, Marais R, Stahel RA.

ESMO Open. 2017 Aug 3;2(3):e000187. doi: 10.1136/esmoopen-2017-000187. eCollection 2017.

40.

Overview on the Biochemical Potential of Filamentous Fungi to Degrade Pharmaceutical Compounds.

Olicón-Hernández DR, González-López J, Aranda E.

Front Microbiol. 2017 Sep 20;8:1792. doi: 10.3389/fmicb.2017.01792. eCollection 2017. Review.

41.

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.

García-Foncillas J, Alba E, Aranda E, Díaz-Rubio E, López-López R, Tabernero J, Vivancos A.

Ann Oncol. 2017 Dec 1;28(12):2943-2949. doi: 10.1093/annonc/mdx501. Review.

42.

Impact of volatile composition on the sensorial attributes of dried paprikas.

Martín A, Hernández A, Aranda E, Casquete R, Velázquez R, Bartolomé T, Córdoba MG.

Food Res Int. 2017 Oct;100(Pt 1):691-697. doi: 10.1016/j.foodres.2017.07.068. Epub 2017 Aug 2.

PMID:
28873738
43.

A comparative study to evaluate natural attenuation, mycoaugmentation, phytoremediation, and microbial-assisted phytoremediation strategies for the bioremediation of an aged PAH-polluted soil.

García-Sánchez M, Košnář Z, Mercl F, Aranda E, Tlustoš P.

Ecotoxicol Environ Saf. 2018 Jan;147:165-174. doi: 10.1016/j.ecoenv.2017.08.012. Epub 2017 Sep 14.

PMID:
28843188
44.

Management of septic shock in intermediate care unit.

Meaudre E, Nguyen C, Contargyris C, Montcriol A, d'Aranda E, Esnault P, Bensalah M, Prunet B, Bordes J, Goutorbe P.

Anaesth Crit Care Pain Med. 2018 Apr;37(2):121-127. doi: 10.1016/j.accpm.2017.07.004. Epub 2017 Aug 5.

PMID:
28790011
45.

Post-hypoxia Invasion of the fetal brain by multidrug resistant Staphylococcus.

Zarate MA, Rodriguez MD, Chang EI, Russell JT, Arndt TJ, Richards EM, Ocasio BA, Aranda E, Gordon EM, Yu K, Neu J, Keller-Wood M, Triplett EW, Wood CE.

Sci Rep. 2017 Jul 25;7(1):6458. doi: 10.1038/s41598-017-06789-6.

46.

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.

Aranda E, Aparicio J, Bilbao JI, García-Alfonso P, Maurel J, Rodríguez J, Sangro B, Vieitez JM, Feliu J.

Future Oncol. 2017 Oct;13(23):2065-2082. doi: 10.2217/fon-2017-0220. Epub 2017 Jul 13. Review.

PMID:
28703622
47.

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).

Carrato A, Abad A, Massuti B, Grávalos C, Escudero P, Longo-Muñoz F, Manzano JL, Gómez A, Safont MJ, Gallego J, García-Paredes B, Pericay C, Dueñas R, Rivera F, Losa F, Valladares-Ayerbes M, González E, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2017 Aug;81:191-202. doi: 10.1016/j.ejca.2017.04.024. Epub 2017 Jun 19.

48.

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.

Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R.

Mol Cancer Ther. 2017 Sep;16(9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. Epub 2017 Jun 16.

49.

Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.

López-Sánchez LM, Jurado-Gámez B, Feu-Collado N, Valverde A, Cañas A, Fernández-Rueda JL, Aranda E, Rodríguez-Ariza A.

Am J Physiol Lung Cell Mol Physiol. 2017 Oct 1;313(4):L664-L676. doi: 10.1152/ajplung.00119.2017. Epub 2017 Jun 15.

50.

Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.

Esnault P, Nguyen C, Bordes J, D'Aranda E, Montcriol A, Contargyris C, Cotte J, Goutorbe P, Joubert C, Dagain A, Boret H, Meaudre E.

Neurocrit Care. 2017 Oct;27(2):187-198. doi: 10.1007/s12028-017-0397-4.

PMID:
28432539

Supplemental Content

Loading ...
Support Center